Description:
|
(1) - Instruction and continuing education in the fields of molecular biology, biotechnology, genetics, medicine and pharmacology; organization of, arranging and conducting conferences, conventions and symposiums; organization of, arranging and conducting seminars and workshops in the fields of molecular biology, biotechnology, genetics, medicine and pharmacology.
(2) - Chemical preparations, namely, buffer, lyophilisates, dispersion solutions, emulsions, suspensions, aerosols, liposomes, additives, polypeptides, for scientific purposes; chemical preparations for the investigation and characterization of diseases; nucleic acids for scientific purposes.
(3) - Medicaments for the treatment of cardiovascular diseases, inflammations, autoimmune diseases, rheumatoid arthritis, psoriasis, atopic dermatitis, gastro-intestinal diseases, Crohn's diseases, ulcerative colitis, diabetes, nephropathy, retinopathy, vasculpathy, vasculitis, transplant rejections, graft versus host and host versus graft diseases, ischaemia, hypertension, aneurysms, renal failure, pulmonary diseases, infectious and post-infectious diseases, namely asthma bronchialis, atopic dermatitis, ulcerative colitis, Morbus Crohn, psoriasis, sarkoidosis, bronchitis, endocarditis, hepatitis, myocarditis, nephritis, pericarditis, peritonitis, pancreatitis and septic shock, immunological disorders, namely immunological hypersensitivity reactions, allergic rhinitis, drug and food allergies, urticaria, celiac disease (sprue), contact eczema, the immune complex diseases, alveolitis, arthritis, glomerulonephritis, allergic vasculitis, inflammatory chondro- and osteopathies, arthrosis, gout, ostitis, osteomyelitis, and polyneuritis, as well as acute and subacute respectively allergic reactions, rhinitis, coronary heart diseases, restenosis, metabolic disorders, malignancies, except neurological disorders.
(4) - Scientific and industrial research and consulting in the fields of molecular biology, biotechnology, genetics, medicine and pharmacology; identification of target structures for the development of medicaments, namely polypeptides and nucleic acids; investigation and development of medicaments and therapies, namely for the control of the expression of genes relevant to diseases; development of processes and products for scientific and industrial research in the fields of molecular biology, biotechnology, genetics, medicine and pharmacology; development of nucleic acids.
(5) - Pharmaceutical and veterinary preparations for the control of the expression of genes relevant to diseases.
(6) - Preparations for diagnosis and analysis of cardiovascular diseases, inflammations, autoimmune diseases, rheumatoid arthritis, psoriasis, atopic dermatitis, gastro-intestinal diseases, Crohn
(7) - Nucleic acids for medical, analytical and diagnostic purposes.
|